JP2019518050A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019518050A5 JP2019518050A5 JP2018565691A JP2018565691A JP2019518050A5 JP 2019518050 A5 JP2019518050 A5 JP 2019518050A5 JP 2018565691 A JP2018565691 A JP 2018565691A JP 2018565691 A JP2018565691 A JP 2018565691A JP 2019518050 A5 JP2019518050 A5 JP 2019518050A5
- Authority
- JP
- Japan
- Prior art keywords
- ring
- alkyl
- compound
- substituted
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16174722.5 | 2016-06-16 | ||
| EP16174722 | 2016-06-16 | ||
| PCT/EP2017/064654 WO2017216283A1 (en) | 2016-06-16 | 2017-06-15 | Heterocyclic compounds as antibacte rials |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019518050A JP2019518050A (ja) | 2019-06-27 |
| JP2019518050A5 true JP2019518050A5 (https=) | 2020-08-13 |
Family
ID=56132839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018565691A Pending JP2019518050A (ja) | 2016-06-16 | 2017-06-15 | 抗菌薬としての複素環式化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200308169A1 (https=) |
| EP (1) | EP3472152A1 (https=) |
| JP (1) | JP2019518050A (https=) |
| KR (1) | KR20190018681A (https=) |
| CN (1) | CN109415349A (https=) |
| AU (1) | AU2017286370B2 (https=) |
| BR (1) | BR112018075939A2 (https=) |
| CA (1) | CA3025727A1 (https=) |
| EA (1) | EA201990044A1 (https=) |
| MA (1) | MA45375A (https=) |
| MX (1) | MX2018015657A (https=) |
| WO (1) | WO2017216283A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017028318B1 (pt) | 2015-07-02 | 2024-02-20 | Janssen Sciences Ireland Uc | Composto antibacteriano, seu uso, processo para sua preparação,produto que o contém, composição farmacêutica e combinação |
| CN108348510B (zh) | 2015-09-17 | 2022-01-04 | 圣母大学 | 针对分枝杆菌感染有用的含有苄胺的杂环化合物以及组合物 |
| BR112018076126A2 (pt) | 2016-06-16 | 2019-03-26 | Janssen Sciences Ireland Unlimited Company | compostos heterocíclicos como antibacterianos |
| EP4417262A3 (en) | 2017-03-01 | 2024-11-27 | Janssen Sciences Ireland Unlimited Company | Combination therapy |
| TWI861208B (zh) | 2019-09-10 | 2024-11-11 | 日商鹽野義製藥股份有限公司 | 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物 |
| WO2021048342A1 (en) | 2019-09-13 | 2021-03-18 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| AU2020358643A1 (en) | 2019-09-30 | 2022-05-26 | Janssen Sciences Ireland Unlimited Company | 4-quinolinone antibacterial compounds |
| JP2022551823A (ja) | 2019-09-30 | 2022-12-14 | ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー | 抗菌化合物 |
| EP4308239A1 (en) | 2021-03-16 | 2024-01-24 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| CN117440958A (zh) | 2021-03-17 | 2024-01-23 | 爱尔兰詹森科学公司 | 抗菌化合物 |
| MX2023010948A (es) | 2021-03-17 | 2023-11-28 | Janssen Sciences Ireland Unlimited Co | Compuestos antibacterianos. |
| WO2022214519A1 (en) | 2021-04-07 | 2022-10-13 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| WO2022214520A1 (en) | 2021-04-07 | 2022-10-13 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| IL312366A (en) | 2021-10-28 | 2024-06-01 | Janssen Sciences Ireland Unlimited Co | Imidazopyridine amides and related compounds for use in the treatment of bacterial infections |
| WO2023115203A1 (en) * | 2021-12-20 | 2023-06-29 | Fairhaven Pharmaceuticals Inc. | Oxer1 antagonists and uses thereof |
| WO2024089170A1 (en) | 2022-10-27 | 2024-05-02 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| WO2024223859A1 (en) | 2023-04-26 | 2024-10-31 | Janssen Pharmaceutica Nv | Antibacterial compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1527050T3 (da) | 2002-07-25 | 2010-07-19 | Janssen Pharmaceutica Nv | Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer |
| EP2496578A4 (en) * | 2009-11-05 | 2013-08-21 | Univ Notre Dame Du Lac | IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF |
| CA2793086C (en) | 2010-03-18 | 2018-08-21 | Institut Pasteur Korea | Substituted imidazo[1,2-a]pyridine compounds and their use in the treatment of bacterial infections |
| US9199981B2 (en) | 2011-09-01 | 2015-12-01 | Novartis Ag | Compounds and compositions as C-kit kinase inhibitors |
| EP2751104B1 (en) | 2011-09-01 | 2019-09-25 | Novartis AG | Compounds and compositions as c-kit kinase inhibitors |
| US9605002B2 (en) * | 2012-07-18 | 2017-03-28 | University Of Notre Dame Du Lac | 5,5-heteroaromatic anti-infective compounds |
| DK3027615T3 (da) * | 2013-08-02 | 2021-10-25 | Pasteur Institut Korea | Antiinfektionsforbindelser |
| CN105524058B (zh) | 2014-10-21 | 2018-03-27 | 广州艾格生物科技有限公司 | 吡唑并[1,5‑a]吡啶类化合物及其应用 |
-
2017
- 2017-06-15 MX MX2018015657A patent/MX2018015657A/es unknown
- 2017-06-15 CN CN201780037163.9A patent/CN109415349A/zh active Pending
- 2017-06-15 CA CA3025727A patent/CA3025727A1/en not_active Abandoned
- 2017-06-15 AU AU2017286370A patent/AU2017286370B2/en not_active Expired - Fee Related
- 2017-06-15 US US16/309,772 patent/US20200308169A1/en not_active Abandoned
- 2017-06-15 EP EP17729495.6A patent/EP3472152A1/en not_active Withdrawn
- 2017-06-15 EA EA201990044A patent/EA201990044A1/ru unknown
- 2017-06-15 WO PCT/EP2017/064654 patent/WO2017216283A1/en not_active Ceased
- 2017-06-15 MA MA045375A patent/MA45375A/fr unknown
- 2017-06-15 JP JP2018565691A patent/JP2019518050A/ja active Pending
- 2017-06-15 BR BR112018075939-2A patent/BR112018075939A2/pt not_active Application Discontinuation
- 2017-06-15 KR KR1020197000961A patent/KR20190018681A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019518050A5 (https=) | ||
| JP2019518046A5 (https=) | ||
| JP2018519302A5 (https=) | ||
| JP2018524339A5 (https=) | ||
| JP2022545359A5 (https=) | ||
| JP2024508755A5 (https=) | ||
| JP2023531311A5 (https=) | ||
| JP2020169171A5 (https=) | ||
| JP2019526596A5 (https=) | ||
| JP2017524025A5 (https=) | ||
| JP2014500295A5 (https=) | ||
| JP2016530259A5 (https=) | ||
| JP2019510787A5 (https=) | ||
| JP2003128673A5 (https=) | ||
| JP2013532652A5 (https=) | ||
| MX2011002348A (es) | Terapia de combinacion para tuberculosis. | |
| HU229935B1 (en) | Dual action antibiotics | |
| JP2019527724A5 (https=) | ||
| JP2021501756A5 (https=) | ||
| JP2022500425A5 (https=) | ||
| JP2013542267A5 (https=) | ||
| JP2011526247A5 (https=) | ||
| JP2019520344A5 (https=) | ||
| JP2011509302A5 (https=) | ||
| JOP20240217A1 (ar) | مشتقات الكوينولين كمُعدِّلات للعضو x2 لمستقبل بروتين g مرتبط بـ mas ومنتجات ذات صلة |